Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

More than 75% of breast cancers that develop in BRCA1 mutation carriers are triple-negative breast cancers (TNBC). The aim of this study was to compare the recurrence-free survival (RFS) and overall survival (OS) in high-risk patients with TNBC with and without deleterious BRCA1/2 mutations. A total...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Breast Cancer Res Treat
Main Authors: Bayraktar, Soley, Gutierrez-Barrera, Angelica M., Liu, Diane, Tasbas, Tunc, Akar, Ugur, Litton, Jennifer K., Lin, E., Albarracin, Constance T., Meric-Bernstam, Funda, Gonzalez-Angulo, Ana M., Hortobagyi, Gabriel N., Arun, Banu K.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4334122/
https://ncbi.nlm.nih.gov/pubmed/21830012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-011-1711-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki